乳腺癌术后经胸乳入路行腔镜甲状腺手术的探讨

Discussion of endoscopic thyroidectomy in breast approach after operation of breast cancer

目的:探讨乳腺癌术后经胸乳入路行腔镜甲状腺手术的安全性、可行性。方法:回顾分析2016年3月至2019年1月为16例乳腺癌术后患者行腔镜甲状腺手术的临床资料(观察组),同时选取2018年1月至2019年1月20例无手术史的经乳晕入路腔镜甲状腺手术患者作为对照(对照组),观察手术时间、术中出血量、术后引流量、术后引流时间、术后并发症、住院时间等指标。结果:两组均顺利完成手术,无中转开放手术。两组手术时间、术中出血量、术后引流量、术后引流时间、术后并发症、住院时间差异无统计学意义(P>0.05)。结论:乳腺癌术后经胸乳入路行腔镜甲状腺手术安全、可行,不会增加术后并发症。

Objective:To investigate the safety and feasibility of endoscopic thyroidectomy via the chest and breast approach after breast cancer surgery.Methods:The clinical data of 16 patients who underwent endoscopic thyroid surgery after breast cancer surgery from Mar.2016 to Jan.2019 were retrospectively analyzed.Meanwhile,20 patients who underwent endoscopic thyroid surgery via the chest and breast approach from Jan.2018 to Jan.2019 without any operation history were selected as the control group.The operative time,intraoperative blood loss,postoperative drainage,postoperative drainage time,postoperative complications and hospital stay were observed.Results:Both groups successfully completed the operation without conversion to open surgery.There was no statistically significant difference between the two groups in operation time,intraoperative blood loss,postoperative drainage volume,postoperative drainage time,postoperative complications and hospital stay(P>0.05).Conclusions:Endoscopic thyroidectomy in breast approach after operation of breast cancer is safe and feasible without increase of postoperative complications.